Company News: Page (1) of 1 - 04/20/17

email article

print page

Phase 1/2 Clinical Trial of Agenus' anti-PD-1 Antibody Begins
First patient dosed; combination trials with anti-PD-1 plus anti-CTLA-4 antibodies planned by year-end
(April 20, 2017) This article is no longer available,but here are some related topics.

Page: 1

Related Keywords: Inc.,Science,Lifestyle,Medical,Biology,Cancer,Other,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

---